Aethlon Medical Inc logo

AEMD - Aethlon Medical Inc Share Price

$1.77 -0.2  -10.6%

Last Trade - 9:00pm

Sector
Healthcare
Size
Micro Cap
Market Cap £18.9m
Enterprise Value £11.2m
Revenue £515k
Position in Universe 5150th / 6337
Bullish
Bearish
Unlock AEMD Revenue
Momentum
Relative Strength (%)
1m +31.0%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -71.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.76 0.89 0.39 0.15 0.23 0.65 1.13 0.15 -3.1%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 March 2020, Aethlon Medical, Inc. revenues increased from $230K to $650K. Net loss increased 3% to $6.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Aethlon segment loss remaining flat at $5.9M. Basic Earnings per Share excluding Extraordinary Items increased from -$5.13 to -$1.87.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

AEMD Revenue Unlock AEMD Revenue

Net Income

AEMD Net Income Unlock AEMD Revenue

Normalised EPS

AEMD Normalised EPS Unlock AEMD Revenue

PE Ratio Range

AEMD PE Ratio Range Unlock AEMD Revenue

Dividend Yield Range

AEMD Dividend Yield Range Unlock AEMD Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
AEMD EPS Forecasts Unlock AEMD Revenue
Profile Summary

Aethlon Medical, Inc. is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities. The Company's lead product is the Aethlon Hemopurifier, which is a device that selectively targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The Aethlon Hemopurifier sheds glycoproteins to treat infectious viral pathogens. In oncology indications, the Hemopurifier targets the removal of circulating exosomes, which are released to promote cancer progression and to seed the spread of metastasis. Through its subsidiary, Exosome Sciences, Inc. (Exosome), the Company is also developing exosome-based product candidates to diagnose and monitor neurological disorders and cancer.

Directors
Last Annual March 31st, 2020
Last Interim March 31st, 2020
Incorporated April 17, 1991
Public Since March 9, 1994
No. of Shareholders: 64
No. of Employees: 8
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Nasdaq Composite ,
Exchange NASDAQ Capital Market
Shares in Issue 12,052,771
Free Float (0.0%)
Eligible for
ISAs
SIPPs
AEMD Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for AEMD
Upcoming Events for AEMD
Wednesday 12th August, 2020 Estimate
Q1 2021 Aethlon Medical Inc Earnings Release
Tuesday 13th October, 2020 Estimate
Aethlon Medical Inc Annual Shareholders Meeting
Friday 30th October, 2020 Estimate
Q2 2021 Aethlon Medical Inc Earnings Release
Frequently Asked Questions for Aethlon Medical Inc
What is the Aethlon Medical Inc share price?

As of 9:00pm, shares in Aethlon Medical Inc are trading at $1.77, giving the company a market capitalisation of £18.9m. This share price information is delayed by 15 minutes.

How has the Aethlon Medical Inc share price performed this year?

Shares in Aethlon Medical Inc are currently trading at $1.77 and the price has moved by -60.6% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Aethlon Medical Inc price has moved by -62.33% over the past year.

What are the analyst and broker recommendations for Aethlon Medical Inc?

Of the analysts with advisory recommendations for Aethlon Medical Inc, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Aethlon Medical Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Aethlon Medical Inc next release its financial results?

Aethlon Medical Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the Aethlon Medical Inc dividend yield?

Aethlon Medical Inc does not currently pay a dividend.

Does Aethlon Medical Inc pay a dividend?

Aethlon Medical Inc does not currently pay a dividend.

When does Aethlon Medical Inc next pay dividends?

Aethlon Medical Inc does not currently pay a dividend.

How do I buy Aethlon Medical Inc shares?

To buy shares in Aethlon Medical Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Aethlon Medical Inc?

Shares in Aethlon Medical Inc are currently trading at $1.77, giving the company a market capitalisation of £18.9m.

Where are Aethlon Medical Inc shares listed? Where are Aethlon Medical Inc shares listed?

Here are the trading details for Aethlon Medical Inc:

Country of listing: United States
Exchange: NAQ
Ticker Symbol: AEMD
What kind of share is Aethlon Medical Inc?

Based on an overall assessment of its quality, value and momentum, Aethlon Medical Inc is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Aethlon Medical Inc share price forecast 2020?

Shares in Aethlon Medical Inc are currently priced at $1.77. At that level they are trading at 0.557% discount to the analyst consensus target price of 0.00.

Analysts covering Aethlon Medical Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.51 for the next financial year.

How can I tell whether the Aethlon Medical Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aethlon Medical Inc. Over the past six months, the relative strength of its shares against the market has been 66.41%. At the current price of $1.77, shares in Aethlon Medical Inc are trading at -14.91% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Aethlon Medical Inc PE Ratio?

We were not able to find PE ratio data for Aethlon Medical Inc.

Who are the key directors of Aethlon Medical Inc?

Aethlon Medical Inc's management team is headed by:

Edward Broenniman - IND
James Frakes - CFO
Chetan Shah - IND
Charles Fisher - CHM
Sabrina Johnson - IND
Guy Cipriani - IND
Timothy Rodell - CEO
Who are the major shareholders of Aethlon Medical Inc?

Here are the top five shareholders of Aethlon Medical Inc based on the size of their shareholding:

Empery Asset Management, L.P. Investment Advisor/Hedge Fund
Percentage owned: 4.2% (507k shares)
Armistice Capital LLC Hedge Fund
Percentage owned: 2.62% (316k shares)
Intracoastal Capital, L.L.C. Corporation
Percentage owned: 1.75% (211k shares)
Sachs Investment Group, LLC Investment Advisor
Percentage owned: 1.06% (127k shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 1.02% (123k shares)
Similar to AEMD
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.